Articles tagged with Covid 19 Vaccines
A study of 1,199 US essential and frontline workers found that recent mRNA vaccination with 2 or 3 doses before infection with Delta or Omicron variants was associated with attenuated symptoms and viral load. Vaccination status also influenced duration of illness and medical care seeking.
Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.
A study of Russian adults found that those who accept vaccination unconditionaly are more likely to have higher trust in government and less frequent social media use. In contrast, vaccine rejectors tend to be more extroverted and friendly but less trusting of institutions.
A recent study by Penn State College of Medicine scientists found that the risk of developing myocarditis — inflammation of the heart muscle — is seven times higher with COVID-19 infection than with COVID-19 vaccination. Patients with myocarditis can experience chest pains, shortness of breath or an irregular heartbeat.
Researchers found that the COVID-19 vaccine can reduce the risk of SARS-CoV-2 placentitis, a condition that causes stillbirth and neonatal death. The vaccine not only protects pregnant women but may also be lifesaving for their unborn children.
The initiative vaccinated a significantly higher rate of young people, non-white populations, and Hispanic people than the average for the state and target communities. The program used a 'double equity' model to engage with local transportation companies and administered over 20,000 COVID-19 vaccination doses.
A new study shows that COVID-19 booster jabs significantly improve immunity against SARS-CoV-2 variants in elderly Singaporeans. The study found that a third vaccine dose boosts low antibody responses and T cell responses in older adults, providing better protection against severe disease.
A nationwide survey found that over 42% of Americans misrepresented their COVID-19 status and/or failed to follow public health measures. The most common reasons were a desire to feel normal and exercise personal freedom, with younger age groups and those with greater distrust of science being more likely to engage in misrepresentation.
The Omicron variant escapes the immune response better than its ancestors, but has also facilitated the transition to a society that can live with COVID-19. The study found that vaccinated individuals develop broader immune responses and experience milder infections.
Researchers recommend prioritizing COVID-19 vaccine access to older people of color and those with high-contact jobs, followed by working-age non-Hispanic whites and Asians. The study found that 'ethnic homophily' matters in vaccination strategies, leading to more deaths prevention.
Research found that pre-existing illnesses and residence in the South region were most often associated with severe outcomes in children. Vaccination was significantly protective across all age groups, with infants having more severe illness than older children. Persistent health disparities across racial and geographic lines were also...
A study of 265 patients found full vaccination status was associated with lower mortality among those intubated due to COVID-19-related acute respiratory distress syndrome. The results may inform discussions on prognosis for families.
A large observational study in Brazil found that mRNA boosting offers considerably better protection against COVID-19 than inactivated CoronaVac boosting, particularly among elderly individuals. The findings have immediate implications for guiding boosting strategies in countries where most of the population received inactivated vaccines.
A large JAMA study found hospitalizations for COVID-19 disease occurred mostly in high-risk patients, including older adults and those with comorbidities. Vaccination and booster shots significantly reduced the incidence of severe COVID-19 illness among all age groups.
A novel COVID-19 vaccine developed by Brazilian scientists combines two SARS-CoV-2 proteins to trigger a cellular immune response. The vaccine, called SpiN, showed promise in animal trials, protecting against three strains of the virus and reducing viral load by up to 50 times.
In some sub-Saharan African countries, up to 88% of adolescents express vaccine hesitancy due to safety and efficacy concerns. The study identifies determinants of this phenomenon, shedding light on strategies to improve vaccination rates in the region.
The study found that imbalances in the host immune system facilitate persistent or severe forms of COVID-19. Low levels of dendritic cells, which report information about invaders to T cells, were associated with long-term infection and disease severity.
A University of Cambridge study has found a significant reduction in long COVID clinic referrals following the vaccine rollout. The study analyzed data from Addenbrooke's Hospital and observed a 79% decrease in patient referrals between August 2021 to June 2022, compared to the previous year.
Moffitt researchers found that cancer patients who believed in vaccine effectiveness and safety were more likely to accept COVID-19 vaccination. High accepters were also more socioeconomically disadvantaged and lived with others, highlighting the need for targeted interventions.
New research highlights the need for comprehensive approaches to address COVID-19 vaccine hesitancy in UK South Asian communities, citing factors such as trust in authorities and media. The study's findings emphasize the complexity of the issue, beyond simplistic 'pro' or 'anti' Vaccine views.
A study found that residents in states with complex COVID-19 vaccine guidelines were less likely to correctly assess their vaccine eligibility. The findings suggest large public health implications for guideline simplicity.
Researchers attribute low vaccination rates in children to misconceptions about vaccine safety and Covid-19 vaccines. Misinformation about vaccine safety predicts reluctance to vaccinate both adults and children.
Researchers have discovered a new pathway for producing telomerase RNA from protein-coding messenger RNA, offering potential innovations in mRNA vaccines and understanding of telomere biology. This finding has implications for reversing cellular aging and extending human lifespan.
A Rutgers-led study statistically evaluated government data to determine if COVID-19 vaccination increases the incidence of Guillain-Barré syndrome. The results show no significant association between any COVID-19 vaccinations and the disease.
A nationwide U.S. study found that mRNA booster immunizations extend COVID-19 protection for four to five months, but immunity begins to wane after this period. The study recommends additional booster doses to maintain high immunity levels against severe COVID.
COVID-19 vaccination during pregnancy was found to lower the risk of severe outcomes including preterm birth and postpartum hemorrhage. Vaccination during pregnancy is now recommended to protect against COVID-19 infection.
A Johns Hopkins Medicine study found that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly among older adults. The results support the CDC vaccination guidelines recommending COVID-19 boosters and highlight the importance of continued research on factors affecting immunity.
A VCU-led study found that evangelical Christians who sought information from their religious leaders were less likely to get vaccinated, while those who spoke with a health care provider were more likely. The study highlights the influence of faith-based and healthcare providers on vaccine decision-making.
Researchers found that air pollutants, particularly fine particles and nitrogen dioxide, increase the risk of COVID-19 hospitalizations up to 30% in vaccinated individuals. Long-term exposure also worsens outcomes, even among those fully vaccinated, highlighting the importance of improving indoor air quality.
Mathematical models suggest that only 1 in 5 COVID-19 cases were counted worldwide, resulting in an estimated 600 million to 2.4 billion actual cases globally. The wide range of estimated cases highlights the problems with accuracy of reported numbers due to data tampering, inconsistent reporting, and lack of uniformity.
A new study published in JAMA highlights the effectiveness of COVID-19 vaccines, boosters, and prior infection in reducing the risk of future infection, hospitalization, and death. The study shows that primary vaccination and booster doses provide strong protection against severe outcomes, even after a year and a half.
Researchers from NAIST found that searches related to vaccine side effects positively correlated with vaccination rates in Japan. The 'vaccine concern index' captured searches of terms indicating vaccine hesitancy, revealing lower concerns among older people and female users.
A new scoring tool prioritizes countries with higher vaccination rates and vulnerable populations, aiming to allocate Covid-19 vaccines more fairly. The tool considers a broader range of factors than current global COVAX facilities, which have been criticized for insufficient access.
A large, real-world study found mRNA COVID-19 vaccines effectively protect against serious disease and hospitalizations in pregnant women. The study provides strong evidence for vaccination as a preventive measure during pregnancy.
A recent study finds that exposure to proteins in common foods, vaccines, bacteria, and viruses can prime the immune system to attack SARS-CoV-2, potentially providing protection against COVID-19. The study's findings suggest that individuals with a history of exposure to these agents may be less susceptible to severe illness.
A large US population study found that receiving a third dose of an mRNA COVID-19 vaccine reduced the risk of hospitalization due to COVID-19 by approximately 60% compared to receiving only two doses. The association was strongest when measured within three months after booster vaccination.
A new study from OHSU reveals that breakthrough infections following vaccination can provide a potent immune response against COVID-19, with increased protection for those 65 and older. The research found an equally strong immune response among people who received a third vaccine booster dose three months prior.
The study estimated vaccine effectiveness against symptomatic Delta and Omicron infections and severe outcomes. Vaccines showed moderate protection against these variants' serious consequences.
Researchers developed a faster, more affordable method to analyze serological data and predict COVID-19 wave behavior. The study showed that vaccination boosted immunity, with hybrid immunity producing higher protection levels. Antibody levels rose quickly after the first dose, especially in cities where case numbers were highest.
Researchers from NAU and University of Washington collaborate to create a safe and effective vaccine for Valley Fever, a fungal infection spreading due to climate change. The project aims to address the growing threat of emerging epidemics and prevent disease through vaccination.
A team of scientists from SMART and NTU Singapore has developed a quick test kit that can determine a person's immunity against COVID-19 and its variants based on antibodies detected in a blood sample. The test kit, which requires just 10 minutes to show results, can be easily adapted for new variants of concern and other diseases.
A team of scientists from SMART and NTU Singapore has developed a rapid point-of-care test kit that measures antibodies against SARS-COV-2 and its variants, offering personalized vaccination strategies. The test kit requires just 10 minutes to show results and has up to 93% accuracy.
A study of Israeli parents found that only 20% of children aged 5-11 have been vaccinated against COVID-19. Parents prioritize returning to school and everyday life over protecting their children from the virus, with many expressing concerns about vaccine safety rather than COVID-19's severity.